Skip to main content
. 2022 Apr 3;14(4):783. doi: 10.3390/pharmaceutics14040783

Figure 11.

Figure 11

IC50 values of free AGN and AGN-PLHNPs against: (A) MCF-7 cells after 24 h; (B) MCF-7 cells after 48 h; (C) MCF-7 cells after 72 h; (D) MDA-MB-231 cells after 24 h; (E) MDA-MB-231 cells after 48 h; and (F) MDA-MB-231 cells after 72 h. ** indicates significant difference between Free AGN and AGN-PLHNPs, (p < 0.05 considered significant).

HHS Vulnerability Disclosure